Published :
Tables : 60
Figures : 50
Category : Healthcare
No. of Pages : 220
Report Code : HC-U3331
Polymerase Chain Reaction Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027. Polymerase chain reaction method is widely used for diagnosing cancer, infectious diseases, in identifying target therapies as per the disease condition and personalized medicine. These are some of the factors contributing to the polymerase chain reaction market growth. This method is quite precise in obtaining results which is why technologies like qPCR and dPCR are highly preferred as they also have advantages like lesser consumption of reagents, workflow automation, real-time process monitoring, etc. Increased incidences of infectious diseases, rising geriatric population, soaring number of hospitals and diagnostic centres and rising adoption of personalised medicine are some driving factors propelling the market growth. With the current COVID-19 pandemic, the importance of polymerase chain reaction has increased tenfold. Reverse Transcription Polymerase Chain Reaction i.e. RT-PCR has been widely used for conducting SARS COV-2 tests. Populous countries like India are unable to carry large-scale tests and this issue can be addressed by conducting pool sample testing. Sample pooling enables the test to be conducted in batches and when the pool is tested positive, the individual samples are assessed. Researchers from IIT Mumbai have developed an algorithm based on combinatorics which identifies which individual samples from a sample pool are positive. Such ventures shall boost the proliferation of the market. However, the dPCR instruments are expensive and there are some fundamental limitations in the qPCR and dPCR technologies shall impede the proliferation of the market. Market Segmentation: By Product • Instruments • Reagents and Consumables • Services • Software By Technology • Traditional PCR • Real-Time PCR • Digital PCR By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into product, technology and region. The product segment is categorised into instruments, reagents and consumables, services and software. The reagents and consumables segment held the largest polymerase chain reaction market share owing to their rising adoption. The technology segment is classified into traditional PCR, real time PCR and digital PCR. The real-time PCR segment is predicted to lead the market, and this can be attributed to the increase adoption of this technology for COVID-19 testing but it is the digital PCR that is expected to augment at a significant rate during the forecast period. Regional Analysis: The North America region is predicted to dominate the market owing to a strong presence of key market players in the region, advancements in the healthcare infrastructure, growing investments for research activities in the PCR technology. Competitive Landscape: Some of the prominent market players are Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd, Bio-Rad Laboratories Inc., Agilent Technologies Inc., BioMerieux S.A., RainDance Technologies Inc., Affymetrix Inc., Fluidigm Corporation, Takara Bio Inc., Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, Siemens Healthcare. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global polymerase chain reaction market by product, by technology and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Polymerase chain reaction method is widely used for diagnosing cancer, infectious diseases, in identifying target therapies as per the disease condition and personalized medicine. These are some of the factors contributing to the polymerase chain reaction market growth. This method is quite precise in obtaining results which is why technologies like qPCR and dPCR are highly preferred as they also have advantages like lesser consumption of reagents, workflow automation, real-time process monitoring, etc. Increased incidences of infectious diseases, rising geriatric population, soaring number of hospitals and diagnostic centres and rising adoption of personalised medicine are some driving factors propelling the market growth. With the current COVID-19 pandemic, the importance of polymerase chain reaction has increased tenfold. Reverse Transcription Polymerase Chain Reaction i.e. RT-PCR has been widely used for conducting SARS COV-2 tests. Populous countries like India are unable to carry large-scale tests and this issue can be addressed by conducting pool sample testing. Sample pooling enables the test to be conducted in batches and when the pool is tested positive, the individual samples are assessed. Researchers from IIT Mumbai have developed an algorithm based on combinatorics which identifies which individual samples from a sample pool are positive. Such ventures shall boost the proliferation of the market. However, the dPCR instruments are expensive and there are some fundamental limitations in the qPCR and dPCR technologies shall impede the proliferation of the market.
Market Segmentation:
By Product • Instruments • Reagents and Consumables • Services • Software By Technology • Traditional PCR • Real-Time PCR • Digital PCR By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into product, technology and region. The product segment is categorised into instruments, reagents and consumables, services and software. The reagents and consumables segment held the largest polymerase chain reaction market share owing to their rising adoption. The technology segment is classified into traditional PCR, real time PCR and digital PCR. The real-time PCR segment is predicted to lead the market, and this can be attributed to the increase adoption of this technology for COVID-19 testing but it is the digital PCR that is expected to augment at a significant rate during the forecast period.
Regional Analysis:
The North America region is predicted to dominate the market owing to a strong presence of key market players in the region, advancements in the healthcare infrastructure, growing investments for research activities in the PCR technology.
Competitive Landscape:
Some of the prominent market players are Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd, Bio-Rad Laboratories Inc., Agilent Technologies Inc., BioMerieux S.A., RainDance Technologies Inc., Affymetrix Inc., Fluidigm Corporation, Takara Bio Inc., Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, Siemens Healthcare.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global polymerase chain reaction market by product, by technology and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Polymerase Chain Reaction Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Instruments 7.2 Reagents and Consumables 7.3 Services 7.4 Software 8. Polymerase Chain Reaction Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Traditional PCR 8.2 Real-Time PCR 8.3 Digital PCR 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Thermo Fisher Scientific Inc. 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Sygnis AG 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 LGC Ltd 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Bio-Rad Laboratories Inc. 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Agilent Technologies Inc. 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 BioMerieux S.A. 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 RainDance Technologies Inc. 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Affymetrix Inc. 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Fluidigm Corporation 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Takara Bio Inc. 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15 Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18 Impact of COVID-19 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. Competitive Intelligence and Competitive Matrix 19.1 Competitive Intelligence 19.2 Competitive Matrix 20. Major Deals and Strategic Alliances Analysis 20.1 Joint ventures 20.2 Mergers and acquisitions 20.3 Licensing and partnerships 20.4 Technology Collaborations 20.5 Strategic Divestments 20.6 Market Entry Strategies 21. Relevant Case Studies and Latest News Updates 22. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics